SCHEMBL1403683

SCHEMBL1403683

CCCCCc1ccc(N=C=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.57
TSHR P16473 2/20 0.57
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
ALDH1A1 P00352 2/20 0.49
ESR1 P03372 2/20 0.48
ADRA2A P08913 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
TACR2 P21452 2/20 0.48
SLC6A2 P23975 2/20 0.48
SLC6A4 P31645 2/20 0.48
SLC6A3 Q01959 2/20 0.48
HSD17B10 Q99714 2/20 0.48
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
SHBG P04278 1/20 0.48
TP53 P04637 1/20 0.48
HSPD1 P10809 1/20 0.48
ADRB3 P13945 1/20 0.48
HTR2C P28335 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2488182 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL5885578 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL991821 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL10400983 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL673425 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL5885366 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL5885475 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL5884680 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL13725699 0.98 CYP3A4 (0.55) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1
SCHEMBL598023 0.94 CYP3A4 (0.59) CYP3A4TSHRCYP2D6CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BASF SE (DE) 2025-12-30 US claimed
CN-117285890-A Preparation method of formaldehyde-free environment-friendly flame-retardant plywood 南宁市匠心鸣居建筑材料有限公司 2023-12-26 CN claimed
US-20230348657-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-11-02 US claimed
EP-4185626-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-05-31 EP claimed
CN-112996835-B Method for producing thermoplastic polyoxazolidone polymers 科思创知识产权两合公司 2022-12-13 CN claimed
US-11427671-B2 Method for the production of thermoplastic polyoxazolidinone polymers COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-08-30 US claimed
EP-3873961-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-08-17 EP claimed
US-11370874-B2 Method for the production of thermoplastic polyoxazolidone polymers COVESTRO DEUTSCHLAND AG (DE) 2022-06-28 US claimed
EP-3873962-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-05-18 EP claimed
EP-3681924-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-05-18 EP claimed
WO-2019052994-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2019-03-21 WO claimed
WO-2019052991-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2019-03-21 WO claimed
EP-3456753-A1 METHOD FOR THE PRODUCTION OF THERMPLASTIC POLYOXAZOLIDINONE POLYMERS Covestro Deutschland AG (DE) 2019-03-20 EP claimed
EP-3456754-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS Covestro Deutschland AG (DE) 2019-03-20 EP claimed
WO-2018141743-A1 METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2018-08-09 WO claimed
EP-3357949-A1 METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS Covestro Deutschland AG (DE) 2018-08-08 EP claimed
WO-2018033562-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2018-02-22 WO claimed
US-20180022871-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY COVESTRO DEUTSCHLAND AG (DE) 2018-01-25 US claimed
EP-3256508-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY Covestro Deutschland AG (DE) 2017-12-20 EP claimed
WO-2016128380-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY COVESTRO DEUTSCHLAND AG (DE) 2016-08-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BMP1, BMP4, PBRM1 CYP3A4 1801/4885TSHR 4875/4885CYP2D6 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.